Our hepato-biliary (HPB) surgery service provides comprehensive care for people with liver, pancreatic, biliary and gall bladder disorders.

We provide advanced laparoscopic surgery for pancreatic and liver tumours and are one of the first centres in the UK to perform the laparoscopic Whipple’s procedure to remove parts of the pancreas, small intestine, bile duct and gallbladder.

According to the National Cancer Intelligence Network (NCIN), our cancer network has the highest three-year survival rate (1999 to date) in the UK. We are also a recognised centre of excellence for neuroendocrine tumours according to the European Neuroendocrine Tumour Society (ENETS).

Conditions and treatments

Our team offers specialist investigations and care for conditions such as primary liver cancer, benign liver tumours, primary biliary cancers (including gallbladder cancer), secondary liver tumours from another primary cancer, pancreatic cancer, pancreatic neuroendocrine tumours (NET), chronic and acute pancreatitis and other complex benign hepato-biliary and pancreatic conditions. We offer a range of specialist surgical and medical treatments for these conditions, including:

• Open and laparoscopic liver, pancreatic and biliary surgeries
• Percutaneous radio-frequency ablation (RFA) and microwave ablation of primary and secondary liver tumours
• Transarterial chemo-embolisation (TACE) for primary liver tumours and percutaneous bland embolisation for liver tumours
• Endoscopic radio-frequency ablation for biliary tumours (endobiliary and EUS RFA)
• Selective internal radiation therapy (SIRT) for primary or secondary liver tumours subject to individual patient funding
• Sorafenib for primary liver cancer – hepatocellular carcinoma (HCC) – subject to individual patient funding or by clinical trial specialist